Innate and adaptive anti-HIV immune responses in the female reproductive tract

Journal of Reproductive Immunology

Volumn 97, Issue 1, 2013, Pages 74-84

  Rodriguez Garcia, Marta ^a   Patel, Mickey V ^a   Wira, Charles R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Adaptive immunity; Epithelial cells; Female reproductive tract; HIV; Immune cells; Innate immunity; Window of vulnerability

Indexed keywords

ESTRADIOL; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PROGESTERONE;

ADAPTIVE IMMUNITY; ARTICLE; DENDRITIC CELL; DISEASE PREDISPOSITION; EPITHELIUM CELL; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INNATE IMMUNITY; MACROPHAGE; MENSTRUAL CYCLE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TROPISM; VIRUS TRANSMISSION;

ADAPTIVE IMMUNITY; ANIMALS; FEMALE; GENITALIA, FEMALE; GONADAL STEROID HORMONES; HIV; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; LUTEAL PHASE;

EID: 84874530466     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.10.010     Document Type: Article

References (143)

1. Aaby P., et al. Age of wife as a major determinant of male-to-female transmission of HIV-2 infection: a community study from rural West Africa. AIDS 1996, 10:1585-1590.
2. Abdool Karim Q., et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010, 329:1168-1174.
3. Ackerman M.E., et al. Emerging concepts on the role of innate immunity in the prevention and control of HIV infection. Annu. Rev. Med. 2012, 63:113-130.
4. Altfeld M., et al. DCs and NK cells: critical effectors in the immune response to HIV-1. Nat. Rev. Immunol. 2011, 11:176-186.
5. Asin S.N., et al. Human immunodefidency virus type 1 infection of human uterine epithelial cells: viral shedding and cell contact-mediated infectivity. J. Infect. Dis. 2003, 187:1522-1533.
6. Asin S.N., et al. Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J. Infect. Dis. 2004, 190:236-245.
7. Arthos J., et al. HIV-1 envelope protein binds to and signals through integrin [alpha]4[beta]7, the gut mucosal homing receptor for peripheral T cells. Nat. Immunol. 2008, 9:301-309.
8. Bahamondes L., et al. The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera. Contraception 2000, 62:23-27.
9. Ballweber L., et al. Vaginal langerhans cells nonproductively transporting HIV-1 mediate infection of T cells. J. Virol. 2011, 85:13443-13447.
10. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
11. Berlier W., et al. Selective sequestration of X4 isolates by human genital epithelial cells: implication for virus tropism selection process during sexual transmission of HIV. J. Med. Virol. 2005, 77:465-474.
12. Bhat S. Galactose to ceramide linkage is essential for the binding of a polyclonal antibody to galactosyl ceramide. J. Neuroimmunol. 1992, 41:105-110.
13. Black C.A., et al. Vaginal mucosa serves as an inductive site for tolerance. J. Immunol. 2000, 165:5077-5083.
14. Blaskewicz C.D., et al. Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia. Biol. Reprod. 2011, 85:97-104.
15. Bobardt M.D., et al. Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J. Virol. 2007, 81:395-405.
16. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat. Med. 1997, 3:42-47.
17. Cassol E., et al. Macrophage polarization and HIV-1 infection. J. Leukoc. Biol. 2010, 87:599-608.
18. Chehimi J., et al. HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages. J. Leukoc. Biol. 2003, 74:757-763.
19. Collins K.B., et al. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat. Med. 2000, 6:475-479.
20. Cone R.A., et al. Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect. Dis. 2006, 6:90.
21. Critchlow C.W., et al. Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching. Am. J. Obstet. Gynecol. 1995, 173:534-543.
22. Cummins J.E., et al. Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob. Agents Chemother. 2007, 51:1770-1779.
23. Cunningham A.L., et al. Manipulation of dendritic cell function by viruses. Curr. Opin. Microbiol. 2010, 13:524-529.
24. Dayal M.B., et al. Disruption of the upper female reproductive tract epithelium by nonoxynol-9. Contraception 2003, 68:273-279.
25. De Witte L., et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 2007, 13:367-371.
26. Deng H., et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
27. Dezzutti C.S., et al. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J. Infect. Dis. 2001, 183:1204-1213.
28. Escribese M.M., et al. Alpha-defensins 1-3 release by dendritic cells is reduced by estrogen. Reprod. Biol. Endocrinol. 2011, 9:118.
29. Fahey J.V., et al. Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in culture. Mucosal. Immunol. 2008, 1:317-325.
30. Feng Y., et al. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877.
31. Furuta Y., et al. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:12559-12563.
32. Galand P., et al. Effect of oestradiol on cell proliferation and histological changes in the uterus and vagina of mice. J. Endocrinol. 1971, 49:243-252.
33. Gebhardt T., et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat. Immunol. 2009, 10:524-530.
34. Ghosh M., et al. CCL20/MIP3α is a novel anti-HIV-1 molecule of the human female reproductive tract. Am. J. Reprod. Immunol. 2009, 62:60-71.
35. Ghosh M., et al. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS ONE 2010, 5:e11366.
36. Ghosh M., et al. Differential susceptibility of HIV strains to innate immune factors in human cervical-vaginal secretions. Virus Adapt. Treat. 2010, 2010:63-71.
37. Givan A.L., et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am. J. Reprod. Immunol. 1997, 38:350-359.
38. Gockel C.M., et al. Influence of the murine oestrous cycle on the induction of mucosal immunity. Am. J. Reprod. Immunol. 2003, 50:369-379.
39. Goldacre M.J., et al. Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. Br. Med. J. 1978, 1:748-750.
40. Greenhead P., et al. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J. Virol. 2000, 74:5577-5586.
41. Gringhuis S.I., et al. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat. Immunol. 2010, 11:419-426.
42. Gumbi P.P., et al. Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection. J. Virol. 2008, 82:8529-8536.
43. Haase A.T. Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu. Rev. Med. 2011, 62:127-139.
44. Haynes B.F., et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 2012, 366:1275-1286.
45. Heffron R., et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect. Dis. 2012, 12:19-26.
46. Hickey D.K., et al. Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J. Reprod. Immunol. 2011, 88:185-194.
47. Hirbod T., et al. In situ distribution of HIV-binding CCR5 and C-Type lectin receptors in the human endocervical mucosa. PLoS ONE 2011, 6:e25551.
48. Hladik F., Mcelrath M.J. Setting the stage: host invasion by HIV. Nat. Rev. Immunol. 2008, 8:447-457.
49. Hladik F., et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007, 26:257-270.
50. Hocini H., et al. Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells. J. Virol. 2001, 75:5370-5374.
51. Horbul J.E., et al. Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture. PLoS ONE 2011, 6:e22638.
52. Howell A., et al. Human Immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J. Virol. 1997, 71:3498-3506.
53. Iijima N., et al. Vaginal epithelial dendritic cells renew from bone marrow precursors. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19061-19066.
54. Iijima N., et al. Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J. Exp. Med. 2008, 205:3041-3052.
55. Iwasaki A. Antiviral immune responses in the genital tract: clues for vaccines. Nat. Rev. Immunol. 2010, 10:699-711.
56. Jain J.K., et al. Nonoxynol-9 induces apoptosis of endometrial explants by both caspase-dependent and -independent apoptotic pathways. Biol. Reprod. 2005, 73:382-388.
57. Kaldensjö T., et al. Detection of intraepithelial and stromal langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection. PLoS ONE 2011, 6:e21344.
58. Kaul R., et al. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J. Immunol. 2000, 164:1602-1611.
59. Kaushic C., et al. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect. Immun. 2000, 68:4207-4216.
60. Keele B.F., et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7552-7557.
61. Keller M.J., et al. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS 2007, 21:467-476.
62. Krebs F.C., et al. Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes. Antimicrob. Agents Chemother. 2000, 44:1954-1960.
63. Kumar R., et al. Compartmentalized secretory leukocyte protease inhibitor expression and hormone responses along the reproductive tract of postmenopausal women. J. Reprod. Immunol. 2011, 92:88-96.
64. Lahey T., et al. Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract. PLoS ONE 2012, 7:e38100.
65. Lambotin M., et al. A look behind closed doors: interaction of persistent viruses with dendritic cells. Nat. Rev. Microbiol. 2010, 8:350-360.
66. Lawrence P., et al. Selective transmigration of monocyte-associated HIV-1 across a human cervical monolayer and its modulation by seminal plasma. AIDS 2012, 26:785-796.
67. Lee V., et al. Relationship of cervical ectopy to chlamydia infection in young women. J. Fam. Plann. Reprod. Health Care 2006, 32:104-106.
68. Li Q., et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005, 434:1148-1152.
69. Li A., et al. Effect of mifepristone on the expression of endometrial secretory leukocyte protease inhibitor in new medroxyprogesterone acetate users. Fertil. Steril. 2008, 90:872-875.
70. Li Q., et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009, 458:1034-1038.
71. Liu K., et al. In vivo analysis of dendritic cell development and homeostasis. Science 2009, 324:392-397.
72. Maher D., et al. HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11504-11509.
73. Marx P.A., et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 1996, 2:1084-1089.
74. Matter K., Balda M.S. Signalling to and from tight junctions. Nat. Rev. Mol. Cell Biol. 2003, 4:225-237.
75. McKinnon L.R., Kaul R. Quality and quantity: mucosal CD4+ T cells and HIV susceptibility. Curr. Opin. HIV AIDS 2012, 7:195-202.
76. McKinnon L.R., et al. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J. Immunol. 2011, 187:6032-6042.
77. Meditz A.L., et al. CCR5 expression is elevated on endocervical CD4+ T cells in healthy postmenopausal women. J. Acquir. Immune Defic. Syndr. 2012, 59:221-228.
78. Meier A., et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat. Med. 2009, 15:955-959.
79. Mestecky J., et al. Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection. J. Reprod. Immunol. 2009, 83:196-200.
80. Mestecky J., et al. Methods for evaluation of humoral immune responses in human genital tract secretions. Am. J. Reprod. Immunol. 2011, 65:361-367.
81. Miller L., et al. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet. Gynecol. 2000, 96:431-439.
82. Moss G.B., et al. Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. J. Infect. Dis. 1991, 164:588-591.
83. Musey L., et al. Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes. J. Virol. 2003, 77:291-300.
84. Nakanishi Y., et al. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 2009, 462:510-513.
85. Nazli A., et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 2010, 6:e1000852.
86. NIAID HIV infection in Women 2010.
87. Nilsson K., et al. The vaginal epithelium in the postmenopause - cytology, histology and pH as methods of assessment. Maturitas 1995, 21:51-56.
88. Ochiel D.O., et al. Human uterine epithelial cell secretions regulate dendritic cell differentiation and responses to TLR ligands. J. Leukoc. Biol. 2010, 88:435-444.
89. Ochiel D.O., et al. Uterine epithelial cell regulation of DC-SIGN expression inhibits transmitted/founder HIV-1 trans infection by immature dendritic cells. PLoS ONE 2010, 5:e14306.
90. Opoku-Anane J., et al. New success with microbicides and pre-exposure prophylaxis for human immunodeficiency virus (HIV): is female-controlled prevention the answer to the HIV epidemic?. Rev. Obstet. Gynecol. 2012, 5:50-55.
91. Owen D.H., Katz D.F. A vaginal fluid simulant. Contraception 1999, 59:91-95.
92. Patel M., et al. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retroviruses 1993, 9:167-174.
93. Patton D.L., et al. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am. J. Obstet. Gynecol. 2000, 183:967-973.
94. Pepper M., Jenkins M.K. Origins of CD4(+) effector and central memory T cells. Nat. Immunol. 2011, 12:467-471.
95. Peretz Y., et al. Dissecting the HIV-specific immune response: a systems biology approach. Curr. Opin. HIV AIDS 2012, 7:17-23.
96. Phillips D.M., et al. Nonoxynol-9 causes rapid exfoliation of sheets of rectal epithelium. Contraception 2000, 62:149-154.
97. Pudney J., et al. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol. Reprod. 2005, 73:1253-1263.
98. Rahm V.A., et al. Chlamydia trachomatis in sexually active teenage girls. Factors related to genital chlamydial infection: a prospective study. Genitourin. Med. 1991, 67:317-321.
99. Randolph G.J., et al. Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol. 2008, 26:293-316.
100. Rerks-Ngarm S., et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 2009, 361:2209-2220.
101. Reynolds M.R., et al. CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little. J. Virol. 2005, 79:9228-9235.
102. Rieger L., et al. Antigen-presenting cells in human endometrium during the menstrual cycle compared to early pregnancy. J. Soc. Gynecol. Investig. 2004, 11:488-493.
103. Rocha-Zavaleta L., et al. Human papillomavirus infection and cervical ectopy. Int. J. Gynaecol. Obstet. 2004, 85:259-266.
104. Rodriguez-Garcia M., et al. Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3. J. Leukoc. Biol. 2007, 82:1143-1146.
105. Rodriguez-Garcia M., et al. Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression. PLoS ONE 2010, 5:e9436.
106. Saidi H., et al. R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission. Virology 2007, 358:55-68.
107. Saidi H., et al. Apical interactions of HIV type 1 with polarized HEC-1 cell monolayer modulate R5-HIV type 1 spread by submucosal macrophages. AIDS Res. Hum. Retroviruses 2009, 25:497-509.
108. Salazar-Gonzalez J.F., et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 2009, 206:1273-1289.
109. Sattentau Q., et al. Epitopes of the CD4 antigen and HIV infection. Science 1986, 234:1120-1123.
110. Schulke L., et al. Endometrial dendritic cell populations during the normal menstrual cycle. Hum. Reprod. 2008, 23:1574-1580.
111. Shacklett B.L., Greenblatt R.M. Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications. Am. J. Reprod. Immunol. 2011, 65:230-241.
112. Sharova N., et al. Macrophages archive HIV-1 virions for dissemination in trans. EMBO J. 2005, 24:2481-2489.
113. Shattock R.J., Rosenberg Z. Microbicides: topical prevention against HIV. Cold Spring Harbor Perspectives in Medicine 2012, 2:a007385.
114. Shen R., et al. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. J. Virol. 2009, 83:3258-3267.
115. Sheridan B.S., Lefrancois L. Regional and mucosal memory T cells. Nat. Immunol. 2011, 12:485-491.
116. Shust G.F., et al. Female genital tract secretions inhibit herpes simplex virus infection: correlation with soluble mucosal immune mediators and impact of hormonal contraception. Am. J. Reprod. Immunol. 2010, 63:110-119.
117. Smith S.M., et al. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS 2004, 18:1637-1643.
118. Southern P.J., et al. Coming of age: reconstruction of heterosexual HIV-1 transmission in human ex vivo organ culture systems. Mucosal. Immunol. 2011, 4:383-396.
119. Starkey P.M., et al. Variation during the menstrual cycle of immune cell populations in human endometrium. Eur. J. Obstet. Gynecol. Reprod. Biol. 1991, 39:203-207.
120. Steinman R.M., Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 2006, 311:17-58.
121. Stoddard E., et al. gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission. J. Immunol. 2007, 179:3126-3132.
122. Stoddard E., et al. gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue. J. Virol. 2009, 83:8596-8603.
123. Tan X., et al. Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission. J. Virol. 1993, 67:6447-6452.
124. Turville S.G., et al. HIV gp120 receptors on human dendritic cells. Blood 2001, 98:2482-2488.
125. UNAIDS Women, Girls, Gender Equality and HIV 2010.
126. Valore E.V., et al. Antimicrobial components of vaginal fluid. Am. J. Obstet. Gynecol. 2002, 187:561-568.
127. Van Der Straten A., et al. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS 2012, 26:F13-F19.
128. White H.D., et al. CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J. Immunol. 1997, 158:3017-3027.
129. White H.D., et al. Mucosal immunity in the human female reproductive tract: cytotoxic T lymphocyte function in the cervix and vagina of premenopausal and postmenopausal women. Am. J. Reprod. Immunol. 1997, 37:30-38.
130. White H.D., et al. Human immunodeficiency virus-specific and CD3-redirected cytotoxic T lymphocyte activity in the human female reproductive tract: lack of correlation between mucosa and peripheral blood. J. Infect. Dis. 2001, 183:977-983.
131. WHO Progress report 2011: global HIV/AIDS response 2011.
132. Wira C.R., et al. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunological Reviews 2005, 206:306-335.
133. Wira C.R., Fahey J.V. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008, 22:1909-1917.
134. Wira C.R., et al. Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am. J. Reprod. Immunol. 2010, 63:544-565.
135. Wira C.R., et al. Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus. Mucosal Immunol. 2011, 4:335-342.
136. Wira C.R., et al. Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am. J. Reprod. Immunol. 2011, 65:196-211.
137. Wu L., Kewalramani V.N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 2006, 6:859-868.
138. Wu Z., et al. Human genital epithelial cells capture cell-free human immunodeficiency virus type 1 and transmit the virus to CD4+ cells: implications for mechanisms of sexual transmission. J. Infect. Dis. 2003, 188:1473-1482.
139. Yeaman G.R., et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J. Leukoc. Biol. 1997, 61:427-435.
140. Yeaman G.R., et al. CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking. Immunology 2001, 102:434-440.
141. Yeaman G.R., et al. Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology 2003, 109:137-146.
142. Yeaman G.R., et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology 2004, 113:524-533.
143. Zhang Z., et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999, 286:1353-1357.